NCT00504803

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning: a Pilot Study

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: University of Liege · Academic / Other
• Sex: All
• Age: 75 Years
• Healthy volunteers: Accepted

Summary

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning from HLA-mismatched PBSC or cord blood: a Pilot Study

Conditions

• Hematological Malignancies

Interventions

Type	Name	Description
PROCEDURE	Mesenchymal stem cell infusion	Infusion of mesenchymal stem cells on the same day as hematopoietic stem cell infusion.

Timeline

• Start date: 2006-12-01
• Primary completion: 2010-12-01
• Completion: 2010-12-01
• First posted: 2007-07-20
• Last updated: 2011-09-02

Locations

1 site across 1 country: Belgium